EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer

Juliana A Camargo, Nayara I Viana iD, Ruan Pimenta iD, Vanessa R Guimarães iD, Gabriel A Dos Santos, Patrícia Candido, Vitória Ghazarian iD, Poliana Romão, Iran A Silva, Alexander Birbrair iD, Miguel Srougi, William C Nahas und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Juliana A Camargo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation (LIM 55), Urology Department, Medicine School, University of Sao Paulo (FMUSP), São Paulo 01246-903, SP, Brazil. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs, Immediate-Early Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, São Paulo Research Foundation (FAPESP) to Juliana Alves de Camargo, Ruan Pimenta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) has a high prevalence and represents an important health problem, with an increased risk of metastasis. With the advance of CRISPR-Cas9 genome editing, new possibilities have been created for investigating PCa. The technique is effective in knockout oncogenes, reducing tumor resistance. MMP9 and miR-21 target genes are associated with PCa progression; therefore, we evaluated the MMP-9 and miR-21 targets in PCa using the CRISPR-Cas9 system. Single guide RNAs (sgRNAs) of MMP9 and miR-21 sequences were inserted into a PX-330 plasmid, and transfected in DU145 and PC-3 PCa cell lines. MMP9 and RECK expression was assessed by qPCR, WB, and IF. The miR-21 targets, integrins, BAX and mTOR, were evaluated by qPCR. Flow cytometry was performed with Annexin5, 7-AAD and Ki67 markers. Invasion assays were performed with Matrigel. The miR-21 CRISPR-Cas9-edited cells upregulated RECK, MARCKS, BTG2, and PDCD4. CDH1, ITGB3 and ITGB1 were increased in MMP9 and miR-21 CRISPR-Cas9-edited cells. Increased BAX and decreased mTOR were observed in MMP9 and miR-21 CRISPR-Cas9-edited cells. Reduced cell proliferation, increased apoptosis and low invasion in MMP9 and miR-21 edited cells was observed, compared to Scramble. CRISPR-Cas9-edited cells of miR-21 and MMP9 attenuate cell proliferation, invasion and stimulate apoptosis, impeding PCa evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMicroRNAsImmediate-Early ProteinsMaleHumansGene EditingCRISPR-Cas SystemsMatrix Metalloproteinase 9RNA, Guide, CRISPR-Cas Systemsbcl-2-Associated X ProteinTOR Serine-Threonine KinasesGPI-Linked ProteinsTumor Suppressor ProteinsRNA-Binding ProteinsApoptosis Regulatory Proteins

Stichwörter der Autor:innen

CRISPR-Cas9matrix metalloproteinasesmetastatic prostate cancermiR-21

Substanzen

Matrix Metalloproteinase 9RNA, Guide, CRISPR-Cas Systemsbcl-2-Associated X ProteinMicroRNAsTOR Serine-Threonine KinasesGPI-Linked ProteinsImmediate-Early ProteinsTumor Suppressor ProteinsRNA-Binding ProteinsRECK protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Investigation (LIM 55), Urology Department, Medicine School, University of Sao Paulo (FMUSP), São Paulo 01246-903, SP, Brazil.
  • Department of Bioscience, Minas Gerais State University (UEMG), Passos 37900-106, MG, Brazil.
  • D'Or Institute for Research and Education (ID'Or), São Paulo 04501-000, SP, Brazil.
  • Department of Pathology, Federal University of Minas Gerais, Belo Horizonte 30190-002, MG, Brazil.
  • Department of Dermatology, University of Wisconsin-Madison, Madison, WI 53715, USA.
  • Department of Radiology, Columbia University Medical Center, New York, NY 10032, USA.

ORCID-Profile: Nayara I Viana, Ruan Pimenta, Vanessa R Guimarães, Vitória Ghazarian, Alexander Birbrair, Kátia R Leite

Förderung

  • São Paulo Research Foundation
  • São Paulo Research Foundation (FAPESP) to Juliana Alves de Camargo
  • Ruan Pimenta
  • Vitória Ghazarian
  • Sabrina T. Reis

Zitieren

APA

Camargo, J. A., Viana, N. I., Pimenta, R., Guimarães, V. R., Dos Santos, G. A., Candido, P., Ghazarian, V., Romão, P., Silva, I. A., Birbrair, A., Srougi, M., Nahas, W. C., Leite, K. R., Trarbach, E. B., & Reis, S. T. (2023). The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914847

Vancouver

Camargo JA, Viana NI, Pimenta R, Guimarães VR, Dos Santos GA, Candido P, et al. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914847

BibTeX
@article{Camargo2023,
  author = {Camargo, Juliana A and Viana, Nayara I and Pimenta, Ruan and Guimarães, Vanessa R and Dos Santos, Gabriel A and Candido, Patrícia and Ghazarian, Vitória and Romão, Poliana and Silva, Iran A and Birbrair, Alexander and Srougi, Miguel and Nahas, William C and Leite, Kátia R and Trarbach, Ericka B and Reis, Sabrina T},
  title = {The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914847}
}
Kostenlos starten →